Germedis - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 237,328 | 297,663 | 287,292 | 489,280 | 512,167 | 298,951 | 490,614 | 384,740 |
| Profit before tax | 60,326 | 61,551 | 44,763 | 118,963 | 98,321 | 32,808 | 102,330 | 29,680 |
| Net profit | 57,310 | 58,473 | 42,525 | 101,119 | 83,573 | 31,159 | 86,980 | 24,928 |
| Equity | 77,685 | 136,158 | 178,682 | 279,801 | 369,374 | 400,532 | 487,512 | 512,054 |
| Liabilities | 68,765 | 3,966 | 24,943 | 25,332 | 41,943 | -2,185 | 44,741 | 4,414 |
| Non-current assets | 3,631 | 16,324 | 14,932 | 14,427 | 68,047 | 55,430 | 148,003 | 127,238 |
| Current assets | 142,819 | 123,800 | 188,693 | 290,706 | 343,270 | 342,917 | 384,250 | 389,230 |
| Total assets | 146,450 | 140,124 | 203,625 | 305,133 | 411,317 | 398,347 | 532,253 | 516,468 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 38,508 | 20,653 | 59,633 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +79.0% | +25.4% | -3.5% | +70.3% | +4.7% | -41.6% | +64.1% | -21.6% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 39.1% | 41.7% | 20.9% | 33.1% | 20.3% | 7.8% | 16.3% | 4.8% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 73.8% | 42.9% | 23.8% | 36.1% | 22.6% | 7.8% | 17.8% | 4.9% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 24.1% | 19.6% | 14.8% | 20.7% | 16.3% | 10.4% | 17.7% | 6.5% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 25.4% | 20.7% | 15.6% | 24.3% | 19.2% | 11.0% | 20.9% | 7.7% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.9 | 0.0 | 0.1 | 0.1 | 0.1 | - | 0.1 | 0.0 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 118,664 | 148,832 | 143,646 | 244,640 | 256,084 | 149,476 | 245,307 | 153,896 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Germedis - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-06-11 | 2026-06-11 | 0.01 |
| 2026-05-17 | 2026-06-08 | 0.01 |
| 2023-11-16 | 2023-12-12 | 0.10 |
| 2023-10-25 | 2023-11-12 | 0.10 |
| 2022-10-28 | 2022-11-10 | 0.11 |
Germedis - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-05-11 | 2025-05-12 | 10.1 |
| 2025-05-06 | 2025-05-10 | 10.46 |
| 2025-05-03 | 2025-05-05 | 10.1 |
| 2024-12-30 | 2024-12-30 | 1395.0 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Germedis, UAB, code 304484861, is a Private Limited Liability Company engaged in activities of agents involved in the wholesale of timber and building materials. In 2025, the company generated revenue of EUR 384.7K and net profit of EUR 24.9K, with a profit margin of 6.5%. Results were weaker than in 2024, when revenue reached EUR 490.6K and net profit EUR 87.0K, but still remained above 2023 levels, when revenue was EUR 299.0K and net profit EUR 31.2K. Over the full 2023–2025 period, revenue increased overall, while profitability peaked in 2024 and then moderated in 2025. At year-end 2025, total assets stood at EUR 516.5K, equity at EUR 512.1K and liabilities at EUR 4.4K, indicating a very strong equity position and minimal leverage. Long-term assets were EUR 127.2K and short-term assets EUR 389.2K. The latest return on equity was 4.9% and return on assets 4.8%. Asset turnover was 0.74x. Revenue per employee was EUR 192.4K and profit per employee EUR 12.5K, showing solid productivity in 2025.